Clinical significance of serum apolipoproteins as a predictor of coronary heart disease risk in Korean men
Summary Objective Although serum apolipoprotein measurement is known to be associated with coronary heart disease (CHD) risk, there is only limited information about the clinical significance of lipid profiles such as ApoA, ApoB and A/B ratio in predicting CHD risk in Asians. Therefore, this cohort...
Saved in:
Published in | Clinical endocrinology (Oxford) Vol. 84; no. 1; pp. 63 - 71 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.01.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Summary
Objective
Although serum apolipoprotein measurement is known to be associated with coronary heart disease (CHD) risk, there is only limited information about the clinical significance of lipid profiles such as ApoA, ApoB and A/B ratio in predicting CHD risk in Asians. Therefore, this cohort study was conducted to evaluate the longitudinal effects of baseline serum apolipoprotein measurements on CHD risk in Korean men.
Design
Initially, an intermediate and high Framingham risk score (FRS)‐free cohort of 23 918 healthy Korean men was followed until 2010. FRS was calculated for each man and divided into three levels of risk <10% (low), 10–19% (intermediate) and ≥20% (high). More‐than‐a‐moderate CHD risk group (participants with FRS ≥ 10%) and high CHD risk group (participants with FRS ≥ 20%) were defined as our two dependent variables. Cox proportional hazards models were performed.
Results
In the more‐than‐a‐moderate CHD risk group, the total and average follow‐up periods were 83340·2 and 3·48 person‐years, respectively, and 3763 (15·7%) incident cases developed between 2006 and 2010. In the high CHD risk group, the total and average follow‐up periods were 87868·8 and 3·67 person‐years, respectively, and 344 (1·4%) incident cases developed between 2006 and 2010. Multivariate‐adjusted analyses showed a strong statistically significant relationship between the quintile groups of apolipoprotein B (ApoB), apolipoprotein A‐1 (ApoA‐1) and apolipoprotein B/apolipoprotein A‐1 (ApoB/A‐1) ratio and both the more‐than‐a‐moderate CHD risk and high CHD risk.
Conclusions
Serum ApoB, ApoA‐1 and ApoB/A‐1 ratio levels are independently associated with CHD risk in Korean men. |
---|---|
Bibliography: | istex:36AD42A22E7ED0D254337B1C4F133126B7396728 ArticleID:CEN12843 Table S1. Comparison between exclusion from analysis and inclusion in analysis. Table S2. Comparison between participants with and without CHD risk in more-than-a-moderate CHD risk group and high CHD risk group. Table S3. Hazard ratios (HRs) and 95% confidence intervals (CI) assessing the independent influence of serum ApoB levels on more-than-a-moderate CHD risk (FRS ≥ 10%) and high CHD risk (FRS ≥ 20%). Table S4. Hazard ratios (HRs) and 95% confidence intervals (CI) assessing the independent influence of serum ApoA-1 levels on more-than-a-moderate CHD risk (FRS ≥ 10%) and high CHD risk (FRS ≥ 20%). Table S5. Hazard ratios (HRs) and 95% confidence intervals (CI) assessing the independent influence of serum LDL/HDL ratio on more-than-a-moderate CHD risk (FRS ≥ 10%) and high CHD risk (FRS ≥ 20%). Table S6. Hazard ratios (HRs) and 95% confidence intervals (CI) assessing the independent influence of serum TC/HDL ratio on more-than-a-moderate CHD risk (FRS ≥ 10%) and high CHD risk (FRS ≥ 20%). ark:/67375/WNG-9JL4BN9X-V ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0300-0664 1365-2265 |
DOI: | 10.1111/cen.12843 |